{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:54:35Z","timestamp":1790268875211,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.revmed.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:14:40Z","timestamp":1596932080000},"page":"607-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diab\u00e8te et cortico\u00efdes\u00a0: nouveaut\u00e9s et aspects pratiques"],"prefix":"10.1016","volume":"41","author":[{"given":"M.","family":"Bastin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Andreelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2020.05.007_bb0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.revmed.2018.03.385","article-title":"Epidemiological description of long-term oral glucocorticoid use: results from the French health insurance database","volume":"39","author":"Couvaras","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2020.05.007_bb0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2020.05.007_bb0015","first-page":"474","article-title":"From insulin resistance to insulinopenia","volume":"60","author":"Andreelli","year":"2010","journal-title":"Rev Prat"},{"key":"10.1016\/j.revmed.2020.05.007_bb0020","doi-asserted-by":"crossref","first-page":"32899","DOI":"10.1074\/jbc.R110.206466","article-title":"Biochemical basis of asthma therapy","volume":"286","author":"Barnes","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2020.05.007_bb0025","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0030","article-title":"Glucocorticoids enhance muscle proteolysis through a myostatin-dependent pathway at the early stage","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2020.05.007_bb0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/me.2008-0464","article-title":"Direct effect of glucocorticoids on lipolysis in adipocytes","volume":"23","author":"Xu","year":"2009","journal-title":"Mol Endocrinol Baltim Md"},{"key":"10.1016\/j.revmed.2020.05.007_bb0040","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1152\/ajpendo.00032.2001","article-title":"Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis","volume":"282","author":"Meyer","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.revmed.2020.05.007_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI111938","article-title":"Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus","volume":"76","author":"DeFronzo","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2020.05.007_bb0050","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1172\/JCI116424","article-title":"Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo","volume":"91","author":"Giorgino","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2020.05.007_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/joe.0.1620067","article-title":"Corticosterone alters insulin signaling in chicken muscle and liver at different steps","volume":"162","author":"Dupont","year":"1999","journal-title":"J Endocrinol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0060","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1074\/jbc.M009489200","article-title":"Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells","volume":"276","author":"Egawa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2020.05.007_bb0065","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1073\/pnas.071050398","article-title":"Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance","volume":"98","author":"Zabolotny","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2020.05.007_bb0070","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00125-004-1447-y","article-title":"Interleukin-6 and insulin sensitivity: friend or foe?","volume":"47","author":"Carey","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.revmed.2020.05.007_bb0075","first-page":"R699","article-title":"Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver","volume":"268","author":"Liao","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0080","doi-asserted-by":"crossref","first-page":"45777","DOI":"10.1074\/jbc.M301977200","article-title":"Interleukin-6 (IL-6) induces insulin resistance in 3\u00a0T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects","volume":"278","author":"Rotter","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2020.05.007_bb0085","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/EJE-09-1034","article-title":"Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men","volume":"162","author":"Van Raalte","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00125-008-0995-y","article-title":"Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans","volume":"51","author":"Ahr\u00e9n","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.revmed.2020.05.007_bb0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2020.05.007_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molmet.2019.12.012","article-title":"Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA","volume":"32","author":"Esguerra","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.revmed.2020.05.007_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.2008.164012","article-title":"Nutritional regulation of glucagon-like peptide-1 secretion","volume":"587","author":"Tolhurst","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0110","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.revmed.2020.05.007_bb0115","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1210\/jc.2010-0119","article-title":"Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects","volume":"95","author":"Hansen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2020.05.007_bb0120","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00125-015-3522-y","article-title":"Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance","volume":"58","author":"Eriksen","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.revmed.2020.05.007_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/CS20140719","article-title":"Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects","volume":"129","author":"Kappe","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.revmed.2020.05.007_bb0130","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1152\/ajpendo.00210.2003","article-title":"Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP\/PDE cascades in MIN6 beta-cells","volume":"286","author":"Shao","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.revmed.2020.05.007_bb0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.revmed.2018.11.004","article-title":"Caract\u00e9ristiques des patients de moins et de plus de 75 ans atteints d\u2019art\u00e9rite \u00e0 cellules g\u00e9antes\u00a0: \u00e9tude comparative de 164 patients","volume":"40","author":"Daumasa","year":"2019","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2020.05.007_bb0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000365892","article-title":"Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis","volume":"65","author":"Liu","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.revmed.2020.05.007_bb0145","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2020.05.007_bb0150","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/dc06-1499","article-title":"Risk of diabetes associated with prescribed glucocorticoids in a large population","volume":"29","author":"Gulliford","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2020.05.007_bb0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1365-2265.2001.01269.x","article-title":"Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy","volume":"54","author":"McConnell","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.revmed.2020.05.007_bb0160","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00125-016-4116-z","article-title":"Steroid-induced hyperglycaemia in hospitalised patients: does it matter?","volume":"59","author":"Cheung","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.revmed.2020.05.007_bb0165","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2020.05.007_bb0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2337\/diab.3.4.296","article-title":"An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone","volume":"3","author":"Fajans","year":"1954","journal-title":"Diabetes"},{"key":"10.1016\/j.revmed.2020.05.007_bb0175","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","article-title":"Drug-induced hyperglycaemia and diabetes","volume":"38","author":"Fathallah","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.revmed.2020.05.007_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1753-0407.12090","article-title":"Glucocorticoid-induced hyperglycemia","volume":"6","author":"Perez","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/j.revmed.2020.05.007_bb0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3346\/jkms.2011.26.2.264","article-title":"Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease","volume":"26","author":"Kim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.revmed.2020.05.007_bb0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diabres.2015.02.010","article-title":"Risk factors for the development of glucocorticoid-induced diabetes mellitus","volume":"108","author":"Katsuyama","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.revmed.2020.05.007_bb0195","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2020.05.007_bb0200","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/dme.13675","article-title":"Joint British Diabetes Societies (JBDS) for inpatient care. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for inpatient care group","volume":"35","author":"Roberts","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.revmed.2020.05.007_bb0205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3803\/EnM.2017.32.2.180","article-title":"Glucocorticoid-induced diabetes mellitus: an important but overlooked problem","volume":"32","author":"Suh","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.revmed.2020.05.007_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016992","article-title":"Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus: A case report with review of literature","volume":"98","author":"Maruyama","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2020.05.007_bb0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/TP.0000000000002815","article-title":"Diabetogenic effects of immunosuppression: an integrative analysis","volume":"104","author":"Bhat","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2020.05.007_bb0220","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/diabetes.53.3.645","article-title":"Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance","volume":"53","author":"Mauvais-Jarvis","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.revmed.2020.05.007_bb0225","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1055\/s-0030-1265131","article-title":"African Americans and Caucasian Americans: differences in glucocorticoid-induced insulin resistance","volume":"42","author":"Frazier","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.revmed.2020.05.007_bb0230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/eurpub\/ckp197","article-title":"Prevalence and characteristics of diabetes among homeless people attending shelters in Paris, France, 2006","volume":"20","author":"Arnaud","year":"2010","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.revmed.2020.05.007_bb0235","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2478\/raon-2018-0034","article-title":"Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia","volume":"52","author":"Gasic","year":"2018","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0240","first-page":"1415","article-title":"Association between NR3C1 gene polymorphisms and toxicity induced by glucocorticoids therapy in Saudi children with acute lymphoblastic leukemia","volume":"19","author":"El-Fayoumi","year":"2018","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.revmed.2020.05.007_bb0245","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/00365521.2015.1132336","article-title":"The impact of genetic factors on response to glucocorticoids therapy in IBD","volume":"51","author":"Gabryel","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1465-9921-10-67","article-title":"Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma","volume":"10","author":"Raby","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.revmed.2020.05.007_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2008.10.001","article-title":"Molecular mechanisms regulating glucocorticoid sensitivity and resistance","volume":"300","author":"Gross","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00467-008-0772-7","article-title":"Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome","volume":"23","author":"Zalewski","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0960-0760(02)00263-7","article-title":"Molecular mechanisms of glucocorticoid action and resistance","volume":"83","author":"Schaaf","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0270","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.2337\/diabetes.51.10.3128","article-title":"A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels","volume":"51","author":"Van Rossum","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.revmed.2020.05.007_bb0275","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ajmg.b.30837","article-title":"Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance","volume":"150B","author":"Kumsta","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.revmed.2020.05.007_bb0280","doi-asserted-by":"crossref","unstructured":"Van Rossum EF, van den Akker EL. Glucocorticoid resistance. Endocr Dev 2011;20:127\u2013136.","DOI":"10.1159\/000321234"},{"key":"10.1016\/j.revmed.2020.05.007_bb0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjmed.2004.01.027","article-title":"Association of the ER22\/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men","volume":"117","author":"Van Rossum","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2020.05.007_bb0290","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/rp.59.1.333","article-title":"Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition","volume":"59","author":"Van Rossum","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.revmed.2020.05.007_bb0295","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/j.1550-8528.1997.tb00292.x","article-title":"Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus","volume":"5","author":"Buemann","year":"1997","journal-title":"Obes Res"},{"key":"10.1016\/j.revmed.2020.05.007_bb0300","first-page":"2270","article-title":"The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus","volume":"86","author":"Dobson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2020.05.007_bb0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.17219\/acem\/41231","article-title":"Glucocorticoid receptor polymorphism in obesity and glucose homeostasis","volume":"26","author":"Majer-\u0141obodzi\u0144ska","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.revmed.2020.05.007_bb0310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1365-2265.2003.01798.x","article-title":"The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients","volume":"59","author":"Di Blasio","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.revmed.2020.05.007_bb0315","first-page":"45","article-title":"Role of glutathione S-transferase enzymes in toxicology, pharmacology and human disease","volume":"661","author":"Vega","year":"2010","journal-title":"Pharmacol. Toxicol. Asp."},{"key":"10.1016\/j.revmed.2020.05.007_bb0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1006\/jmbi.1998.1708","article-title":"Structure\u2013activity relationships and thermal stability of human glutathione transferase P1\u20131 governed by the H-site residue 105","volume":"278","author":"Johansson","year":"1998","journal-title":"J Mol Biol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0325","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00467-006-0187-2","article-title":"Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response","volume":"21","author":"Wasilewska","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0330","first-page":"170","article-title":"Early incidence of glucocorticoid-induced diabetes in patients with brain tumors: a retrospective study of the first 7\u00a0days of treatment","volume":"5","author":"Schultz","year":"2018","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.revmed.2020.05.007_bb0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-16-0653","article-title":"Metformin prevents metabolic side effects during systemic glucocorticoid treatment","volume":"176","author":"Seelig","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0340","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1060028017728297","article-title":"Optimizing the treatment of steroid-induced hyperglycemia","volume":"52","author":"Wallace","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.revmed.2020.05.007_bb0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1758-5996-6-3","article-title":"Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome","volume":"6","author":"Fransson","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.revmed.2020.05.007_bb0350","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc10-1677","article-title":"Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans","volume":"34","author":"Van Raalte","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2020.05.007_bb0355","doi-asserted-by":"crossref","first-page":"983453","DOI":"10.1155\/2014\/983453","article-title":"Augmented \u03b2-cell function and mass in glucocorticoid-treated rodents are associated with increased islet Ir-\u03b2\/AKT\/mTOR and decreased AMPK\/ACC and AS160 signaling","volume":"2014","author":"Protzek","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.revmed.2020.05.007_bb0365","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imj.12680","article-title":"Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients","volume":"45","author":"Burt","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.revmed.2020.05.007_bb0370","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem-70-4-1114","article-title":"Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity","volume":"70","author":"Campbell","year":"1990","journal-title":"J Clin Endocrinol Metab"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320301910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320301910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:41:56Z","timestamp":1759336916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866320301910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0248866320301910"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.05.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diab\u00e8te et cortico\u00efdes\u00a0: nouveaut\u00e9s et aspects pratiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}